Article
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
Nature communications - 17 Mar 2021
Zhang Baotong, Li Yixiang, Wu Qiao, Xie Lin, Barwick Benjamin, Fu Changying, Li Xin, Wu Daqing, Xia Siyuan, Chen Jing, Qian Wei Ping, Yang Lily, Osunkoya Adeboye O, Boise Lawrence, Vertino Paula M, Zhao Yichao, Li Menglin, Chen Hsiao-Rong, Kowalski Jeanne, Kucuk Omer, Zhou Wei, Dong Jin-Tang
Abstract excerpt
Advanced prostate cancer (PCa) often develops bone metastasis, for which therapies are very limited and the underlying mechanisms are poorly understood. We report that bone-borne TGF-β induces the acetylation of transcription factor KLF5 in PCa bone metastases, and acetylated KLF5 (Ac-KLF5) causes osteoclastogenesis and bone metastatic lesions by activating CXCR4, which leads to IL-11 secretion, and stimulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
